Showing results (21-30 of 331) with videos related to
Sort By:
Pageof 34
Drug and Alcohol Dependence|July 4, 2002
4-MTA: a new synthetic drug on the dance sceneAdam R Winstock, Kim Wolff, John RamseyJournal of Substance Abuse Treatment|December 11, 2020
Depot buprenorphine during COVID-19 in Australia: Opportunities and challengesShalini Arunogiri, Nicholas LintzerisThe International Journal on Drug Policy|August 10, 2014
Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug usersHanna Uosukainen, Ulrich Tacke, Adam R WinstockJournal of Psychopharmacology (Oxford, England)|November 29, 2013
Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sampleAdam R Winstock, Stephen Kaar, Rohan BorschmannThe American Journal on Addictions|February 6, 2010
Benzodiazepines, methadone and buprenorphine: interactions and clinical managementNicholas Lintzeris, Suzanne NielsenTranslational Psychiatry|September 6, 2022
Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabisTabea Schoeler, Jason Ferris, Adam R WinstockThe Medical Journal of Australia|June 14, 2006
National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in AustraliaAdam R Winstock, Caroline M Anderson, Janie SheridanPain Management|September 2, 2025
Buvidal/Brixadi - a long-acting injectable buprenorphine formulation for the treatment of opioid dependenceNicholas Lintzeris, Adrian J DunlopDrug and Alcohol Review|April 14, 2015
Methoxetamine: An early report on the motivations for use, effect profile and prevalence of use in a UK clubbing sampleAdam R Winstock, Will Lawn, Paolo Deluca, et al.The International Journal on Drug Policy|June 1, 2016
Safer scoring? Cryptomarkets, social supply and drug market violenceMonica J Barratt, Jason A Ferris, Adam R WinstockPageof 34